Literature DB >> 16932350

Flt-3 internal tandem duplication hampers differentiation of AML blasts towards leukemic dendritic cells.

I Houtenbos, T M Westers, C J Hess, Q Waisfisz, G J Ossenkoppele, A A van de Loosdrecht.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16932350     DOI： 10.1038/sj.leu.2404348

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  5 in total

Review 1.  Clinical trials of dendritic cell-based cancer vaccines in hematologic malignancies.

Authors:  Athalia R Pyzer; David E Avigan; Jacalyn Rosenblatt
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 2.  Dendritic Cells of Leukemic Origin: Specialized Antigen-Presenting Cells as Potential Treatment Tools for Patients with Myeloid Leukemia.

Authors:  Daniel Christoph Amberger; Helga Maria Schmetzer
Journal:  Transfus Med Hemother       Date:  2020-11-05       Impact factor: 3.747

3.  Down-regulation of signal transducer and activator of transcription 3 improves human acute myeloid leukemia-derived dendritic cell function.

Authors:  Michael T Brady; Austin Miller; Sheila N Sait; Laurie A Ford; Hans Minderman; Eunice S Wang; Kelvin P Lee; Heinz Baumann; Meir Wetzler
Journal:  Leuk Res       Date:  2013-04-28       Impact factor: 3.156

4.  Elevated frequencies of leukemic myeloid and plasmacytoid dendritic cells in acute myeloid leukemia with the FLT3 internal tandem duplication.

Authors:  Mareike Rickmann; Juergen Krauter; Kathrin Stamer; Michael Heuser; Gustavo Salguero; Eva Mischak-Weissinger; Arnold Ganser; Renata Stripecke
Journal:  Ann Hematol       Date:  2011-04-26       Impact factor: 3.673

Review 5.  Dendritic cell-based immunotherapy for myeloid leukemias.

Authors:  Christian M Schürch; Carsten Riether; Adrian F Ochsenbein
Journal:  Front Immunol       Date:  2013-12-31       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.